4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-25-005355
Chief Medical Officer acquired 16,233 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Deliargyris Efthymios Chief Medical Officer | 2025-01-17 | Option exercise | +16,233 | $1.00 | $16,233 | 403,025 | D |
| Derivatives | |||||||
| Deliargyris Efthymios Chief Medical Officer | 2025-01-17 | Option exercise · Subscription Rights (right to buy) | −16,233 | 0 | D | ||
| Deliargyris Efthymios Chief Medical Officer | 2025-01-17 | Other acquisition · Series A Right Warrants | +16,233 | 16,233 | D | ||
| Deliargyris Efthymios Chief Medical Officer | 2025-01-17 | Other acquisition · Series B Right Warrants | +16,233 | 16,233 | D | ||
Loading xslF345X05/tm254168-2_4seq1.xml…